þÿ
...by analysis of such features as relationship to dose, relationship to drug concentration,disappearance on.....results of studies, by postmarketing experience, or by information on similar drugs.....metabolite concentrations is usually of interest, PD information is frequently collected in dose-response studies or together..
http://www.fda.gov/cder/guidance/4539E.pdf (score=100)

MDI and DPI Drug Products
...The guidance sets forth information that should be provided to ensure continuing drug.....also known as oral and nasal metered dose inhalers respectively or MDIs) and inhalation.....establish a set of criteria to which a drug substance or drug product should conform using..
http://www.fda.gov/cder/guidance/2180dft.pdf (score=101)

April 2000 Safety-Related Drug Labeling Changes
...To reduce the chance of a drug-drug interaction, cyclosporine should be taken at least 2 hours.....Consult the compete prescribing information for Agenerase Oral Solution for full.....The recommended daily dose of Agenerase Oral Solution of 22.5 mg/kg twice daily..
http://www.fda.gov/medwatch/safety/2000/apr00.htm (score=99)

þÿ
...nursing or to discontinue the drug, taking into account the importance of the drug to the.....Following single intravenous doses, dose-proportional pharmacokinetics were shown in the.....Information for Patients.. MOBIC, like other drugs of its class, can cause discomfort and..
http://www.fda.gov/cder/foi/label/2000/20938lbl.pdf (score=96)

Document Information Page
...dose that produced mean plasma drug levels about 30 times higher than the mean plasma drug.....Information for Patients.. Patients should be advised about substances they should not.....180 mg/kg/day, a dose that produced mean plasma drug levels about 12 times higher than the..
http://www.fda.gov/cder/foi/label/2002/19766s56lbl.pdf (score=95)

þÿ
...drug is physiologically concentrated or in situations where high dosage of drug can be.....The pharmacokinetics of a single 320 mg dose of gemifloxacin were also studied in patients.....susceptibility information are available, they should be considered in selecting or..
http://www.fda.gov/cder/foi/label/2003/21158_factive_lbl.pdf (score=95)

Regulatory Information
...Human Drug Current Good Manufacturing Practice Notes is a periodic memo on Current Good.....This FDA Office of Public Affairs page provides information on IRB operations and clinical.....Since most of the metered-dose inhalers (MDIs) available in the United States contain..
http://www.fda.gov/cder/regulatory/default.htm (score=94)

Preventable Adverse Drug Reactions: A focus on drug interactions
...2 Ultra-rapid metabolism results in lower blood levels following a standard dose of any drug.....The previous slides have reviewed information about the magnitude of adverse drug.....1 However, they will experience codeine’s adverse effects, particularly if the dose is..
http://www.fda.gov/cder/drug/drugReactions/default.htm (score=94)

...Office of Training and Communications Division of Communication Management Drug Information.....The guidance reflects the Agency's current recommendations regarding the integration of.....Department of Health and Human Services Food and Drug Administration Center for Drug..
http://www.fda.gov/cder/guidance/5308FNL.doc (score=94)

A Dose of Clear Directions for Rx Drug Users
...Under the action plan, health professionals will voluntarily provide prescription drug.....instructions for proper use, including the usual doses, instructions if a scheduled dose.....Useful prescription drug information must reach at least 75 percent of patients by the year..
http://www.fda.gov/fdac/features/1997/597_drug.html (score=94)

Guidance for Industry
...oral inhalation integrate a dose-counting device into the development of their MDI drug product.Dose.....to obtain this information. Note that in either case, these studies do not need to.....metered dose are more clinically important for oral inhalation drug products than for the..
http://www.fda.gov/cder/guidance/5308FNL.pdf (score=93)

Kaletra Information
...Lopinavir's antiviral properties are combined with a low dose of ritonavir that inhibits.....The new drug is used in combination with other anti-HIV drugs. It should be taken with.....The usual dose for adults is three capsules or 5.0 mL twice a day. Dosing for children..
http://www.fda.gov/cder/drug/infopage/kaletra/default.htm (score=91)

Microsoft Word - 5341fnl.doc
...pharmacological effect or clinical benefit effect in relation to dose or drug concentration.The.....responses at that dose, but do not provide information about the distribution of individual dose-response.....subsequent titration steps based on response to the drug, as well as information on how to..
http://www.fda.gov/cder/guidance/5341fnl.pdf (score=91)

/a//content.23634
...confirmatory characterization of safety and/ Phase II that a drug is safe and effective.....present data, information, or views, Lane, Rockville, MD 20857, 301­827­ Manufacturers.....tolerability of the dose range expected to be.. duration of drug exposure in patients at..
http://www.fda.gov/cder/guidance/1857fnl.pdf (score=90)

Reviewer Guidance: Evaluation of Human Pregnancy Outcome Data
...includes information about the exposure itself including dose, duration, and gestational.....3 Throughout this document, the term drug includes therapeutic biological agents and.....information more broadly, including information that relates to toxicities that may be..
http://www.fda.gov/cber/gdlns/rvrpreg.pdf (score=89)

Document
...to convene a panel of pediatric experts, existing drug advisory committees, FDA agrees.....1 In one case, pediatric use information provided for one of two approved indications.2 In.....limited information gain. submission of pediatric use information, scientifically, legally..
http://www.fda.gov/ohrms/dockets/98fr/120298c.pdf (score=89)

A Dose of Clear Directions for Rx Drug Users: From Test Tube to Patient:...
...patient information for about 40 pre- past, thanks to the new "Action Plan for the.....Patients who get drug information.. possibly related to the drug; are prescribed for very.....a scheduled dose is missed, special.. severe acne. may be dangerous if taken with cer..
http://www.fda.gov/cder/about/whatwedo/testtube-14.pdf (score=87)

Content and Format of the Adverse Reactions Section of Labeling for Human...
...The ADVERSE REACTIONS section of the labeling should contain drug safety information that is important.....Data in the primary table should be derived from placebo-controlled and/or dose-response.....The overview is intended to briefly highlight the information in a drug_s adverse reaction profile that is..
http://www.fda.gov/cder/guidance/1888dft.htm (score=87)

Packaging
...For inhalation or oral dose aerosols, complete information about the actuator, including data showing that it can.....During the early investigational stages of a drug, it may not be necessary to supply this.....When metered-dose valves are used, full information is also necessary with respect to..
http://www.fda.gov/cder/guidance/package.htm (score=87)

Draft Guidance for Industry Content and Format of the Adverse Reactions...
...reporting, whether the adverse reaction rate for drug exceeds the placebo rate, extent of dose-response, extent to which the.....The overview is intended to briefly highlight the information in a drug=s adverse reaction.....reactions that exhibit a dose-response and describe the manner in which dose-response was..
http://www.fda.gov/cber/gdlns/cfadvers.pdf (score=86)

Las Vegas Injury Lawyer